Gill J, Ahluwalia MK, Geller D, Gorlick R. New targets and approaches in osteosarcoma. Pharmacol Ther. 2013;137(1):89–99.
Article
PubMed
CAS
Google Scholar
Abarrategi A, Tornin J, Martinez-Cruzado L, Hamilton A, Martinez-Campos E, Rodrigo JP, et al. Osteosarcoma: cells-of-origin, Cancer stem cells, and targeted therapies. Stem Cells Int. 2016;2016:3631764.
Article
PubMed
PubMed Central
CAS
Google Scholar
Osborne TS, Khanna C. A review of the association between osteosarcoma metastasis and protein translation. J Comp Pathol. 2012;146(2–3):132–42.
Article
PubMed
PubMed Central
CAS
Google Scholar
Jackson TM, Bittman M, Granowetter L. Pediatric malignant bone tumors: a review and update on current challenges, and emerging drug targets. Curr Probl Pediatr Adolesc Health Care. 2016;46(7):213–28.
Article
PubMed
Google Scholar
Wang Z, Li B, Ren Y, Ye Z. T-cell-based immunotherapy for osteosarcoma: challenges and opportunities. Front Immunol. 2016;7:353.
PubMed
PubMed Central
Google Scholar
Saeter G, Hoie J, Stenwig AE, Johansson AK, Hannisdal E, Solheim OP. Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival. Cancer. 1995;75(5):1084–93.
Article
PubMed
CAS
Google Scholar
De AHC, Busam K, Salob S. Cutaneous metastasis of osteosarcoma. J Am Acad Dermatol. 2003;49:457–60.
Google Scholar
Gok Durnali A, Paksoy Turkoz F, Ardic Yukruk F, Tokluoglu S, Yazici OK, Demirci A, et al. Outcomes of adolescent and adult patients with lung metastatic osteosarcoma and comparison of synchronous and Metachronous lung metastatic groups. PLoS One. 2016;11(5):e0152621.
Article
PubMed
PubMed Central
CAS
Google Scholar
Meazza C, Scanagatta P. Metastatic osteosarcoma: a challenging multidisciplinary treatment. Expert Rev Anticancer Ther. 2016;16(5):543–56.
Article
PubMed
CAS
Google Scholar
Shaikh AB, Li F, Li M, He B, He X, Chen G, et al. Present advances and future perspectives of molecular targeted therapy for osteosarcoma. Int J Mol Sci. 2016;17(4):506.
Article
PubMed
PubMed Central
CAS
Google Scholar
Maximov VV, Aqeilan RI. Genetic factors conferring metastasis in osteosarcoma. Future Oncol. 2016;12(13):1623–44.
Article
PubMed
CAS
Google Scholar
Kanao H, Enomoto T, Kimura T, Fujita M, Nakashima R, Ueda Y, et al. Overexpression of LAMP3/TSC403/DC-LAMP promotes metastasis in uterine cervical cancer. Cancer Res. 2005;65(19):8640–5.
Article
PubMed
CAS
Google Scholar
Nagelkerke A, Bussink J, Mujcic H, Wouters BG, Lehmann S, Sweep FC, et al. Hypoxia stimulates migration of breast cancer cells via the PERK/ATF4/LAMP3-arm of the unfolded protein response. Breast Cancer Res. 2013;15(1):R2.
Article
PubMed
PubMed Central
CAS
Google Scholar
Nagelkerke A, Mujcic H, Bussink J, Wouters BG, van Laarhoven HW, Sweep FC, et al. Hypoxic regulation and prognostic value of LAMP3 expression in breast cancer. Cancer. 2011;117(16):3670–81.
Article
PubMed
CAS
Google Scholar
Liao X, Chen Y, Liu D, Li F, Li X, Jia W. High expression of LAMP3 is a novel biomarker of poor prognosis in patients with esophageal squamous cell carcinoma. Int J Mol Sci. 2015;16(8):17655–67.
Article
PubMed
PubMed Central
CAS
Google Scholar
Liu K, He Q, Liao G, Han J. Identification of critical genes and gene interaction networks that mediate osteosarcoma metastasis to the lungs. Exp Ther Med. 2015;10(5):1796–806.
Article
PubMed
PubMed Central
CAS
Google Scholar
Papiol S, Arias B, Barrantes-Vidal N, Guitart M, Salgado P, Catalan R, et al. Analysis of polymorphisms at the tumor suppressor gene p53 (TP53) in contributing to the risk for schizophrenia and its associated neurocognitive deficits. Neurosci Lett. 2004;363(1):78–80.
Article
PubMed
CAS
Google Scholar
Li J, Yang L, Gaur S, Zhang K, Wu X, Yuan YC, et al. Mutants TP53 p.R273H and p.R273C but not p.R273G enhance Cancer cell malignancy. Hum Mutat. 2014;35(5):575–84.
Article
PubMed
CAS
Google Scholar
Chen Z, Guo J, Zhang K, Guo Y. TP53 mutations and survival in osteosarcoma patients: a meta-analysis of published data. Dis Markers. 2016;2016:4639575.
PubMed
PubMed Central
Google Scholar
Poos K, Smida J, Nathrath M, Maugg D, Baumhoer D, Neumann A, et al. Structuring osteosarcoma knowledge: an osteosarcoma-gene association database based on literature mining and manual annotation. Database (Oxford). 2014(12):2159–60.
Ru J-Y, Cong Y, Kang W-B, Yu L, Tin Guo ZJ-N. Polymorphisms in TP53 are associated with risk and survival of osteosarcoma in a Chinese population. Int J Clin Exp Pathol. 2015;8(3):3198–203.
PubMed
PubMed Central
CAS
Google Scholar
Bisio A, Zamborszky J, Zaccara S, Lion M, Tebaldi T, Sharma V, et al. Cooperative interactions between p53 and NFkappaB enhance cell plasticity. Oncotarget. 2014;5(23):12111–25.
Article
PubMed
PubMed Central
Google Scholar
Ke Y, Tang H, Ye C, Lei CT, Wang YM, Su H, et al. Role and Association of Inflammatory and Apoptotic Caspases in renal Tubulointerstitial fibrosis. Kidney Blood Press Res. 2016;41(5):643–53.
Article
PubMed
CAS
Google Scholar
Bueno MJ, Perez de Castro I, Gomez de Cedron M, Santos J, Calin GA, Cigudosa JC, et al. Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell. 2008;13(6):496–506.
Article
PubMed
CAS
Google Scholar
Dias SS, Milne DM, Meek DW. C-Abl phosphorylates Hdm2 at tyrosine 276 in response to DNA damage and regulates interaction with ARF. Oncogene. 2006;25(50):6666–71.
Article
PubMed
CAS
Google Scholar
Gong JG, Costanzo A, Yang HQ, Melino G, Kaelin WG Jr, Levrero M, et al. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature. 1999;399(6738):806–9.
Article
PubMed
CAS
Google Scholar
Sionov RV, Coen S, Goldberg Z, Berger M, Bercovich B, Ben-Neriah Y, et al. c-Abl regulates p53 levels under normal and stress conditions by preventing its nuclear export and ubiquitination. Mol Cell Biol. 2001;21(17):5869–78.
Article
PubMed
CAS
Google Scholar
Tang W, Xue R, Weng S, Wu J, Fang Y, Wang Y, et al. BIRC6 promotes hepatocellular carcinogenesis: interaction of BIRC6 with p53 facilitating p53 degradation. Int J Cancer. 2015;136(6):E475–87.
Article
PubMed
CAS
Google Scholar
Yang J, Li S, Wang B, Wu Y, Chen Z, Lv M, et al. Potential biomarkers for anti-EGFR therapy in metastatic colorectal cancer. Tumour Biol. 2016;37(9):11645–55.
Article
PubMed
CAS
Google Scholar